Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

AQSTAQST
Showing 5 of 7 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in AQUESTIVE THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 744,536 shares of AQST (AQUESTIVE THERAPEUTICS INC), worth $3.1M as of 2026-Q2. The position was decreased (-74.3% shares). AQST represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$3.1M

Current Shares

744,536

Total Value Change

+$3M

Total Shares Change

+715,599

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
744,536
-74.3%
$3.1M0.0%$4.16
0
2026-Q1
Increased
2.9M
+198.7%
$12M0.0%$4.12
45
2025-Q4
New
970,939
-
$6.3M0.0%$6.38
38
2024-Q4
Exited
0
-100.0%
$00.0%$3.52
0
2024-Q3
New
28,937
-
$144,1060.0%$4.72
31

Other major holders of AQST: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used